Evotec entered into a research agreement with Biogen Idec to find hit molecules against a target selected by Biogen Idec. The firm has the option to add more targets.


Evotec will provide Biogen Idec with access to its full range of screening technologies and library of compounds. The company will use its background in protein production and assay development to develop new assays for the initial target.

Previous articlePerkinElmer Makes Two Acquisitions to Pad Diagnostics Business in Emerging Markets
Next articleSwine Flu’s Ability to Attach to Lung Receptors Increases Chance of Respiratory Problems